Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 3, 2013Journal of Translational MedicineOpen Access

Forkhead box transcription factor 1 expression in gastric cancer: FOXM1 is a poor prognostic factor and mediates resistance to docetaxel

View Full Paper
Ask AI
Bookmark
Share

Authors

XLXiaoxiao LiBinzhou Medical UniversityWQWensheng QiuQingdao UniversityBLBin LiuLuminex (United States)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Li et al. (2013) studied this question.

synapsesocial.com/papers/6aaa2f20d8a51181c01bf08ehttps://doi.org/10.1186/1479-5876-11-204
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Melanoma-associated antigen-A1 expression predicts resistance to docetaxel and paclitaxel in advanced and recurrent gastric cancer2007 · 31 citations
  2. 2FoxM1B Is Overexpressed in Human Glioblastomas and Critically Regulates the Tumorigenicity of Glioma Cells2006 · 318 citations
  3. 3Quality of life in patients with advanced gastric cancer: a randomized trial comparing docetaxel, cisplatin, 5-FU (TCF) with epirubicin, cisplatin, 5-FU (ECF)2006 · 46 citations
  4. 4Phase II Study of Low-Dose Docetaxel/Fluorouracil/Cisplatin in Metastatic Gastric Carcinoma2005 · 44 citations